Derma Sciences Inc (NASDAQ:DSCI)
| 13.94 Data as of May 20 |  -0.35 / -2.45%Today’s Change | 8.80 Today|||52-Week Range 14.92 | +25.47% Year-to-Date |
Latest DSCI News | Press Releases
| Why Derma Sciences May Be About to Take Off 1:07am / MotleyFool.com | Company News for May 17, 2013 - Corporate Summary May 17 / Zacks.com |
| DSCI January 2014 Options Begin Trading May 20 / TheStreet.com | Derma Sciences Increases Sales but Misses Estimates on Earnings May 16 / MotleyFool.com |
Today’s Trading
| Previous close | 14.29 |
| Today’s open | 14.29 |
| Day’s range | -- - -- |
| Volume | 18,553 |
| Average volume (3 months) | 38,830 |
| Market cap | $242.6M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/20/2013
Growth & Valuation
| Earnings growth (last year) | -97.96% |
| Earnings growth (this year) | -76.29% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +16.00% |
| P/E ratio | NM |
| Price/Sales | 1.91 |
| Price/Book | 2.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RTIXRTI Biologics Inc | +0.04 | +0.92% |
| VASCVascular Solutions I... | -0.39 | -2.47% |
| ATECAlphatec Holdings In... | -0.07 | -3.52% |
| ZLTQZELTIQ Aesthetics In... | +0.02 | +0.40% |
Data as of 4:00pm ET, 05/20/2013
Financials
| Last reporting date | May 16, 2013 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $72.6M |
| Annual profit (last year) | -$12.1M |
| Net profit margin | -16.61% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Edward J. Quilty, MBA |
Executive Vice President- Operations Frederic Eigner, MBA |
Corporate headquarters Princeton, New Jersey |
Forecasts
